No. 17-1616

Regeneron Pharmaceuticals, Inc. v. Merus N.V.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Motion for leave to file amici brief filed by Seven Chicago Patent Lawyers GRANTED.

Brief of respondent Merus N.V. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including August 8, 2018.

Motion to extend the time to file a response from July 9, 2018 to August 8, 2018, submitted to The Clerk.

Response Requested. (Due July 9, 2018)

DISTRIBUTED for Conference of 6/21/2018.

Waiver of right of respondent Merus N.V. to respond filed.

Petition for a writ of certiorari filed. (Response due July 2, 2018)

Application (17A945) granted by The Chief Justice extending the time to file until May 25, 2018.

Application (17A945) to extend the time to file a petition for a writ of certiorari from March 26, 2018 to May 25, 2018, submitted to The Chief Justice.


Regeneron Pharmaceuticals, Inc., Petitioner, represented by Neal Kumar Katyal

Merus N.V., Respondent, represented by John Caviness O'Quinn

Last updated: May 18, 2024